Medi Caps Ltd vs Roselabs Finance Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 27, 2026

Key Highlights

The Latest Trading Price of Medi Caps Ltd is ₹ 31.47 as of 27 May 15:30 . The P/E Ratio of Medi Caps Ltd changed from 4.5 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Roselabs Finance Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Medi Caps Ltd changed from ₹ 50.32 crore on March 2021 to ₹ 51.76 crore on March 2025 . This represents a CAGR of 0.57% over 5 yearsThe Market Cap of Roselabs Finance Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Medi Caps Ltd for the Mar '26 is ₹ 9.04 crore as compare to the Dec '25 revenue of ₹ 5.06 crore. This represent the growth of 78.66% The revenue of Roselabs Finance Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Medi Caps Ltd for the Mar '26 is ₹ 3.53 crore as compare to the Dec '25 ebitda of ₹ -0.3 crore. This represent the decline of -1276% The ebitda of Roselabs Finance Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Medi Caps Ltd changed from ₹ -0.56 crore to ₹ 3.04 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Roselabs Finance Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Medi Caps Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Roselabs Finance Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Medi Caps Ltd

Medi Caps Limited was incorporated by S L Mittal in August, 1983 as a Private Limited Company and was converted into a Public Limited Company in Mar.'86.
Pharmaceutical companies procure empty hard gelatine capsules from Medi Caps for dosaged medicines meant for oral administration.
The company is the second-largest manufacturer of empty hard gelatine capsules in India. It takes several years for a company manufacturing capsules to attain zero-defect in production and to fully normalise operations.
Medi-caps can claim to have achieved this.
In Apr.'95, the company offered 6.11 lac rights shares to part-finance the Rs 9.20 crore expansion of its manufacturing facilities by installing four high-speed automatic capsule-making machines. The company's manufacturing unit is located in Pithampur, Madhya Pradesh.

About Roselabs Finance Ltd

Roselabs Finance Limited, a part of Lodha Group, was incorporated on 4th January, 1995.
Initially, the Company was engaged in the business of Non-Banking Finance. In 2012-13, through the open offer formalities as prescribed under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, the Company became a direct subsidiary of Arihant Premises Private Limited and step down subsidiary of Lodha Developers Private Limited, w.e.f. 10th June, 2013.
Accordingly in terms of the open offer, erstwhile promoters, Poonam Fast foods Pvt.
Ltd ceased to be the promoter of the Company and Arihant Premises Private Limited became the Promoter of the Company w.e.f. 10th June, 2013. In 2018-19, the Company had applied to Reserve Bank of India for voluntary deregistration of the Company's Certificate of Registration as a Non-Banking Financial Institution in July 2017.

FAQs for the comparison of Medi Caps Ltd and Roselabs Finance Ltd

Which company has a larger market capitalization, Medi Caps Ltd or Roselabs Finance Ltd?

Market cap of Medi Caps Ltd is 39 Cr while Market cap of Roselabs Finance Ltd is 21 Cr

What are the key factors driving the stock performance of Medi Caps Ltd and Roselabs Finance Ltd?

The stock performance of Medi Caps Ltd and Roselabs Finance Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medi Caps Ltd and Roselabs Finance Ltd?

As of May 27, 2026, the Medi Caps Ltd stock price is INR ₹31.47. On the other hand, Roselabs Finance Ltd stock price is INR ₹21.47.

How do dividend payouts of Medi Caps Ltd and Roselabs Finance Ltd compare?

To compare the dividend payouts of Medi Caps Ltd and Roselabs Finance Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.